trending Market Intelligence /marketintelligence/en/news-insights/trending/wpcxbcqsijzk8hbcbdteyq2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

The Medicines Co. names Purdue Pharma, Merck executive as CEO

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


The Medicines Co. names Purdue Pharma, Merck executive as CEO

The Medicines Co. has appointed Mark Timney as CEO and board member, effective immediately.

Timney replaces Clive Meanwell, who has been named the company's chief innovation officer. Timney has been CEO and president of Purdue Pharma Inc. since Jan. 27, 2014, and was previously president of Merck & Co. Inc.

Parsippany, N.J.-based The Medicines Co. is a biopharmaceutical company that provides medicines to treat acute and intensive care patients.